Product Withdrawal Can Be As Hard As Approval: Luveris' 4-Year Journey Ends
This article was originally published in The Pink Sheet Daily
Executive Summary
EMD Serono had not marketed the infertility treatment in US since 2012, when it first asked FDA to withdraw application; company was unable to complete confirmatory trial required under accelerated approval.